Regulation of Alveolarization

Fetal and Neonatal Physiology: Third Edition

Volumn 1-2, Issue , 2003, Pages 794-801

  Snyder, Jeanne M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 14344259818     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50080-1     Document Type: Chapter

References (125)

1. Weibel ER, Taylor CR Functional design of the human lung for gas exchange. Fishman's Pulmonary Diseases and Disorders 1998, 21-61. McGraw-Hill, New York. G.P. Fishman (Ed.).
2. Langston C, Kida K, Reed M, Thurlbeck WM Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984, 129:607-613.
3. Hislop AA, Wigglesworth JS, Desai R Alveolar development in the human fetus and infant. Early Hum Dev 1986, 13:1-11.
4. Husain AN, Siddiqui NH, Stocker JT Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998, 29:710-717.
5. Jobe AH, Ikegami M Prevention of bronchopulmonary dysplasia. Curr Opin Pediatr 2001, 13:124-129.
6. Coalson JJ, Winter V, deLemos RA Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995, 152:640-646.
7. Gilbert KA, Petrovic-Dovat L, Rannels DE Hormonal control of compensatory lung growth. Lung Growth and Development, Lung Biology in Health and Disease 1997, 627-666. Marcel Dekker, New York. J.A. MacDonald (Ed.).
8. Takeda S, Hsia CC, Wagner E, Ramanathan M, Estrera AS, Weibel ER Compensatory alveolar growth normalizes gas-exchange function in immature dogs after pneumonectomy. J Appl Physiol 1999, 86:1301-1310.
9. Massaro D, Massaro GD Invited Review: pulmonary alveoli: formation, the "call for oxygen," and other regulators. Am J Physiol 2002, 282:L345-L358.
10. Massaro GD, Massaro D Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol 1996, 270:L305-L310.
11. Massaro GD, Massaro D Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997, 3:675-677.
12. Weibel ER, Crystal RG Structural organization of the pulmonary interstitium. The Lung: Scientific Foundations 1997, 685-695. Lippincott-Raven, Philadelphia. R.G. Crystal (Ed.).
13. Mallampalli RK, Acarregui MJ, Snyder JM Differentiation of the alveolar epithelium in the fetal lung. Lung Growth and Development 1997, 119-162. Marcel Dekker, New York. J.E. MacDonald (Ed.).
14. Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 1983, 128:S42-S46.
15. Frerking I, Gunther A, Seeger W, Pison U Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 2001, 27:1699-1717.
16. Zeltner TB, Burri PH The postnatal development and growth of the human lung. II. Morphology. Respir Physiol 1987, 67:269-282.
17. Margraf LR, Tomashefski JF, Bruce MC, Dahms BB Morphometric analysis of the lung in bronchopulmonary dysplasia. Am Rev Respir Dis 1991, 143:391-400.
18. Snyder JM, Mendelson CR, Johnston JM The morphology of human fetal lung development. Pulmonary Development in Transition from Intrauterine to Extrauterine Life 1985, 19-46. Marcel Dekker, New York. G.H. Nelson (Ed.).
19. Perl AK, Wert SE, Nagy A, Lobe CG, Whitsett JA Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci USA 2002, 99:10482-10487.
20. Burri PH, Dbaly J, Weibel ER The postnatal growth of the rat lung. I. Morphometry. Anat Rec 1974, 178:711-730.
21. Amy RW, Bowes D, Burri PH, Haines J, Thurlbeck WM Postnatal growth of the mouse lung. J Anat 1977, 124:131-151.
22. Massaro GD, Massaro D Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation. Annu Rev Physiol 1996, 58:73-92.
23. Randell SH, Mercer RR, Young SL Neonatal hyperoxia alters the pulmonary alveolar and capillary structure of 40-day-old rats. Am J Pathol 1990, 136:1259-1266.
24. Kauffman SL Cell proliferation in the mammalian lung. Int Rev Exp Pathol 1980, 22:131-191.
25. McGowan SE, Torday JS The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development. Annu Rev Physiol 1997, 59:43-62.
26. Kapachi Y GG Contractile cells in pulmonary alveolar tissue. Scientific Foundations 1997, 697-707. Lippincott-Raven, Philadelphia. R.G. Crystal (Ed.).
27. Bostrom H, Willetts K, Pekny M, et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 1996, 85:863-873.
28. Lindahl P, Karlsson L, Hellstrom M, et al. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development 1997, 124:3943-3953.
29. Mariani TJ, Pierce RA Development of lung elastic matrix. Lung Development 1999, 28-45. Oxford University Press, New York. C. Gaultier, J.R. Bourbon, M. Post (Eds.).
30. Mercer RR, Crapo JD Spatial distribution of collagen and elastin fibers in the lungs. J Appl Physiol 1990, 69:756-765.
31. Bairos V, Goncalves C, Figueiredo M Study of the elastic fibres' framework of the rat lung. Ital J Anat Embryol 1995, 100(Suppl 1):431-439.
32. Honda T, Ishida K, Hayama M, Kubo K, Katsuyama T Type II pneumocytes are preferentially located along thick elastic fibers forming the framework of human alveoli. Anat Rec 2000, 258:34-38.
33. Noguchi A, Firsching K, Kursar JD, Reddy R Developmental changes of tropoelastin synthesis by rat pulmonary fibroblasts and effects of dexamethasone. Pediatr Res 1990, 28:379-382.
34. Bruce MC Developmental changes in tropoelastin mRNA levels in rat lung: evaluation by in situ hybridization. Am J Respir Cell Mol Biol 1991, 5:344-350.
35. Kida K, Thurlbeck WM Lack of recovery of lung structure and function after the administration of beta-amino-propionitrile in the postnatal period. Am Rev Respir Dis 1980, 122:467-475.
36. Crouch E, Mecham R, Davila R, Noguchi A Collagens and elastic fibers in lung development. Lung Growth and Development, Lung Biology in Health and Disease 1997, 327-364. Marcel Dekker, New York. J. MacDonald (Ed.).
37. Tanaka R, Al-Jamal R, Ludwig MS Maturational changes in extracellular matrix and lung tissue mechanics. J Appl Physiol 2001, 91:2314-2321.
38. Sannes PL, Wang J Basement membranes and pulmonary development. Exp Lung Res 1997, 23:101-108.
39. deMello DE, Sawyer D, Galvin N, Reid LM Early fetal development of lung vasculature. Am J Respir Cell Mol Biol 1997, 16:568-581.
40. Burri PH, Tarek MR A novel mechanism of capillary growth in the rat pulmonary microcirculation. Anat Rec 1990, 228:35-45.
41. Ferrara N Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 2000, 55:15-35. discussion 35-16.
42. Lassus P, Turanlahti M, Heikkila P, et al. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001, 164:1981-1987.
43. Ng YS, Rohan R, Sunday ME, Demello DE, D'Amore PA Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 2001, 220:112-121.
44. Zeng X, Wert SE, Federici R, Peters KG, Whitsett JA VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn 1998, 211:215-227.
45. Brown KR, England KM, Goss KL, Snyder JM, Acarregui MJ VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol 2001, 281:L1001-L1010.
46. Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002, 8:702-710.
47. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000, 106:1311-1319.
48. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol 2002, 283:L555-L562.
49. Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol 2000, 279:L600-L607.
50. Jobe AH, Bancalari E Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 163:1723-1729.
51. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 164:1971-1980.
52. Albertine KH, Jones GP, Starcher BC, et al. Chronic lung injury in preterm lambs: disordered respiratory tract development. Am J Respir Crit Care Med 1999, 159:945-958.
53. D'Angio CT, Maniscalco WM The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci 2002, 7:d1609-d1623.
54. Loughna S, Sato TN Angiopoietin and Tie signaling pathways in vascular development. Matrix Biol 2001, 20:319-325.
55. Kullander K, Klein R Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 2002, 3:475-486.
56. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 2002, 12:13-19.
57. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol 2002, 282:L811-L823.
58. Chinoy MR, Graybill MM, Miller SA, Lang CM, Kauffman GL Angiopoietin-1 and VEGF in vascular development and angiogenesis in hypoplastic lungs. Am J Physiol 2002, 283:L60-L66.
59. Kagoshima M, Ito T Diverse gene expression and function of semaphorins in developing lung: positive and negative regulatory roles of semaphorins in lung branching morphogenesis. Genes Cells 2001, 6:559-571.
60. Ito T, Kagoshima M, Sasaki Y, et al. Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung. Mech Dev 2000, 97:35-45.
61. Betsholtz C, Karlsson L, Lindahl P Developmental roles of platelet-derived growth factors. Bioessays 2001, 23:494-507.
62. Han RN, Mawdsley C, Souza P, Tanswell AK, Post M Platelet-derived growth factors and growth-related genes in rat lung. III. Immunolocalization during fetal development. Pediatr Res 1992, 31:323-329.
63. Bostrom H, Gritli-Linde A, Betsholty C PDGF-A/PDGF alpha-receptor signaling is required for lung growth and the formation of alveoli but not for early lung branching morphogenesis. Dev Dyn 2002, 223:155-162.
64. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 2001, 32:76-91.
65. Liggins GC Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969, 45:515-523.
66. Liggins GC, Howie RN A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50:515-525.
67. Massaro D, Massaro GD Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition. Am J Physiol 1986, 251:R218-R224.
68. Willet KE, McMenamin P, Pinkerton KE, et al. Lung morphometry and collagen and elastin content: changes during normal development and after prenatal hormone exposure in sheep. Pediatr Res 1999, 45:615-625.
69. Massaro D, Teich N, Maxwell S, Massaro GD, Whitney P Postnatal development of alveoli: regulation and evidence for a critical period in rats. J Clin Invest 1985, 76:1297-1305.
70. Bunton TE, Plopper CG Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque. Am J Obstet Gynecol 1984, 148:203-215.
71. Muglia LJ, Bae DS, Brown TT, et al. Proliferation and differentiation defects during lung development in corticotropin-releasing hormone-deficient mice. Am J Respir Cell Mol Biol 1999, 20:181-188.
72. Cole TJ, Blendy JA, Monaghan AP, et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995, 9:1608-1621.
73. Jobe AH Pulmonary surfactant therapy. N Engl J Med 1993, 328:861-868.
74. Jobe AH Glucocorticoids, inflammation and the perinatal lung. Semin Neonatol 2001, 6:331-342.
75. Chytil F The lungs and vitamin A. Am J Physiol 1992, 262:L517-L527.
76. Chytil F Retinoids in lung development. FASEB J 1996, 10:986-992.
77. Chambon P The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog Horm Res 1995, 50:317-332.
78. Massaro GD, Massaro D, Chan WY, et al. Retinoic acid receptor-beta: an endogenous inhibitor of the perinatal formation of pulmonary alveoli. Physiol Genomics 2000, 4:51-57.
79. Massaro GD, Massaro D Formation of alveoli in rats: postnatal effect of prenatal dexamethasone. Am J Physiol 1992, 263:L37-L41.
80. 2-induced inhibition of lung septation. Am J Physiol 2002, 283:L971-L980.
81. McGowan S, Jackson SK, Jenkins-Moore M, Dai HH, Chambon P, Snyder JM Mice bearing deletions of retinoic acid receptors demonstrate reduced lung elastin and alveolar numbers. Am J Respir Cell Mol Biol 2000, 23:162-167.
82. McGowan SE, Doro MM, Jackson SK Endogenous retinoids increase perinatal elastin gene expression in rat lung fibroblasts and fetal explants. Am J Physiol 1997, 273:L410-L416.
83. Shenai JP, Chytil F Vitamin A storage in lungs during perinatal development in the rat. Biol Neonate 1990, 57:126-132.
84. McGowan SE, Harvey CS, Jackson SK Retinoids, retinoic acid receptors, and cytoplasmic retinoid binding proteins in perinatal rat lung fibroblasts. Am J Physiol 1995, 269:L463-L472.
85. Shenai JP, Kennedy KA, Chytil F, Stahlman MT Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987, 111:269-277.
86. Kennedy KA, Stoll BJ, Ehrenkranz RA, et al. Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: has the dose been too low? The NICHD Neonatal Research Network. Early Hum Dev 1997, 49:19-31.
87. Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely-low-birth-weight infants: National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999, 340:1962-1968.
88. Walter R, Gottlieb DJ, O'Connor GT Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease. Environ Health Perspect 2000, 108(Suppl 4):733-742.
89. Mao JT, Goldin JG, Dermand J, et al. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med 2002, 165:718-723.
90. Nielsen HC, Torday JS Sex difference in fetal lung development. Endocrinology of the Lung 2000, 141-159. Human Press, Totowa, NJ. C.R. Mendelson (Ed.).
91. Torday JS, Nielsen HC, Fencl M de M, Avery ME Sex differences in fetal lung maturation. Am Rev Respir Dis 1981, 123:205-208.
92. Massaro GD, Mortola JP, Massaro D Estrogen modulates the dimensions of the lung's gas-exchange surface area and alveoli in female rats. Am J Physiol 1996, 270:L110-L114.
93. Massaro GD, Mortola JP, Massaro D Sexual dimorphism in the architecture of the lung's gas-exchange region. Proc Natl Acad Sci USA 1995, 92:1105-1107.
94. Challis JRG, Matthews SG, Gibb W, Lye SJ Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000, 21:514-550.
95. Trotter A, Maier L, Pohlandt F Management of the extremely preterm infant: is the replacement of estradiol and progesterone beneficial?. Paediatr Drugs 2001, 3:629-637.
96. Gonzales-Pacheco DM, Buss WC, Koehler KM, Woodside WF, Alpert SS Energy restriction reduces metabolic rate in adult male Fisher-344 rats. J Nutr 1993, 123:90-97.
97. Sahebjami H, Wirman JA Emphysema-like changes in the lungs of starved rats. Am Rev Respir Dis 1981, 124:619-624.
98. Massaro G, Radaeva S, Clerch LB, Massaro D Lung alveoli: endogenous programmed destruction and regeneration. Am J Physiol 2002, 283:L305-L309.
99. Massaro D MG Pulmonary alveolus formation: critical period, retinoid regulation and plasticity. Novartis Found Symp 2001, 229-241.
100. Tenney SM, Remmers JE Comparative quantitative morphology of the mammalian lung diffusing area. Nature 1963, 197:54-56.
101. 2 on the growing lung, adaption of the growing rat lung to hypoxia and hyperoxia. Respir Physiol 1971, 11:247-264.
102. Randell SH, Mercer RR, Young SL Postnatal growth of pulmonary acini and alveoli in normal and oxygen-exposed rats studied by serial section reconstructions. Am J Anat 1989, 186:55-68.
103. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 1997, 16:557-567.
104. McGrath-Morrow SA, Stahl J Apoptosis in neonatal murine lung exposed to hyperoxia. Am J Respir Cell Mol Biol 2001, 25:150-155.
105. Moore LG Human genetic adaptation to high altitude. High Alt Med Biol 2001, 2:257-279.
106. 2. Am J Physiol 1991, 261:L370-L377.
107. 2 and a critical period. Am J Physiol 1990, 258:L321-L327.
108. Speer CP Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999, 158(Suppl 1):S18-S22.
109. Jobe AH, Ikegami M Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001, 2:27-32.
110. Clark RH, Gerstmann DR, Jobe AH, Moffitt ST, Slutsky AS, Yoder BA Lung injury in neonates: causes, strategies for prevention, and long-term consequences. J Pediatr 2001, 139:478-486.
111. Lyon A Chronic lung disease of prematurity: the role of intra-uterine infection. Eur J Pediatr 2000, 159:798-802.
112. Parks WC, Shapiro SD Matrix metalloproteinases in lung biology. Respir Res 2001, 2:10-19.
113. Crouch E, Wright JR Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001, 63:521-554.
114. Wert SE, Yoshida M, LeVine AM, et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 2000, 97:5972-5977.
115. Hawgood S, Ochs M, Jung A, et al. Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema. Am J Physiol 2002, 283:L1002-L1010.
116. Jeffery PK Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease. Novartis Found Symp 2001, 234:149-161. discussion 161-148.
117. Chung KF Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001, 34:50s-59s.
118. Barnes PJ Cytokine modulators as novel therapies for airway disease. Eur Respir J Suppl 2001, 34:67s-77s.
119. Massaro D, Teich N, Massaro GD Postnatal development of pulmonary alveoli: modulation in rats by thyroid hormones. Am J Physiol 1986, 250:R51-R55.
120. Ware LB, Matthay MA Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol 2002, 282:L924-L940.
121. Weinstein M, Xu X, Ohyama K, Deng CX FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 1998, 125:3615-3623.
122. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV The molecular basis of lung morphogenesis. Mech Dev 2000, 92:55-81.
123. Costa RH, Kalinichenko VV, Lim L Transcription factors in mouse lung development and function. Am J Physiol 2001, 280:L823-L838.
124. Mariani TJ, Reed JJ, Shapiro SD Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix. Am J Respir Cell Mol Biol 2002, 26:541-548.
125. Waterston RH, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562.